Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Inventory Average (2021 - 2023)

Historic Inventory Average for ADC Therapeutics (ADCT) over the last 3 years, with Q3 2023 value amounting to $21.1 million.

  • ADC Therapeutics' Inventory Average rose 3869.39% to $21.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $21.1 million, marking a year-over-year increase of 3869.39%. This contributed to the annual value of $6.0 million for FY2022, which is N/A changed from last year.
  • As of Q3 2023, ADC Therapeutics' Inventory Average stood at $21.1 million, which was up 3869.39% from $18.8 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Inventory Average ranged from a high of $21.1 million in Q3 2023 and a low of $7863.0 during Q3 2021
  • For the 3-year period, ADC Therapeutics' Inventory Average averaged around $11.1 million, with its median value being $13.9 million (2022).
  • Its Inventory Average has fluctuated over the past 5 years, first soared by 19317864.68% in 2022, then soared by 3869.39% in 2023.
  • Over the past 3 years, ADC Therapeutics' Inventory Average (Quarter) stood at $4.4 million in 2021, then surged by 218.02% to $13.9 million in 2022, then surged by 51.54% to $21.1 million in 2023.
  • Its Inventory Average was $21.1 million in Q3 2023, compared to $18.8 million in Q2 2023 and $15.2 million in Q1 2023.